Datavault AI Inc. Receives Nasdaq Extension to Regain $1.00 Bid Price

What Happened

• Datavault AI Inc. announced in an 8-K that Nasdaq notified the company it failed to meet the $1.00 minimum closing bid requirement and did not cure the deficiency by the initial deadline of August 24, 2026.
• On August 25, 2026, Nasdaq granted a 180-calendar-day extension (the Second Compliance Period) giving Datavault until February 22, 2027 to regain compliance. Trading of Datavault’s common stock will continue on the Nasdaq Capital Market under the ticker "DVLT" during this period.

Key Details

• Nasdaq originally notified the company on February 24, 2026 after 30 consecutive business days below $1.00; initial cure period ran through August 24, 2026.
• Extension granted August 25, 2026 provides an additional 180 days, ending February 22, 2027.
• To cure the deficiency, the bid price must close at $1.00 or more for at least 10 consecutive business days during the extension period.
• Nasdaq granted the extension because Datavault met other initial listing requirements (e.g., market value of publicly held shares) and indicated steps it may take to cure the deficiency, including a potential reverse stock split.

Why It Matters

• If Datavault fails to meet the $1.00 minimum bid price by February 22, 2027, Nasdaq will notify the company of delisting and trading could be removed from Nasdaq unless an appeal succeeds—this could reduce liquidity and make shares harder to trade.
• The extension preserves current Nasdaq trading status for now, but investors should monitor the company’s share price, any corporate actions (such as a reverse stock split), and further announcements about compliance or appeals.